PRESS RELEASE published on 03/02/2026 at 15:18, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group discloses 5.08% stake in JTC plc. Purchased 15,442 securities at 13.04 GBP per unit. No derivative transactions or other dealings reported Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase JTC Plc
PRESS RELEASE published on 03/02/2026 at 15:17, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.25% stake in Bluefield Solar Income Fund Limited. No additional disclosures made. Date of disclosure: 02 March 2026 Investment Vanguard Group Financial Disclosure Stake Disclosure Bluefield Solar
PRESS RELEASE published on 03/02/2026 at 15:16, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.04% ownership of Beazley plc shares. Public disclosure under Rule 8.3 of the Takeover Code on 02 March 2026 The Vanguard Group, Inc. Rule 8.3 Takeover Code Ownership Disclosure Beazley Plc
PRESS RELEASE published on 03/02/2026 at 15:15, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.52% position in Schroders plc as of 27 February 2026. Details provided in Form 8.3 for public disclosure Securities Form 8.3 Position Disclosure The Vanguard Group Schroders Plc
PRESS RELEASE published on 03/02/2026 at 15:15, 6 months 8 days ago Sirma Group Holding AD makes share buyback Sirma Group Holding AD announces share buyback of 17,570 own shares at EUR 1.17 per share, totaling EUR 20,526.90 Share Buyback Sirma Group Holding EUR 1.17 Bulgarian Stock Exchange Sofia AD
PRESS RELEASE published on 03/02/2026 at 15:15, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% ownership in Spire Healthcare Group plc. Purchase of 1p ordinary securities at 2.03 GBP per unit Vanguard Group Ownership Disclosure Spire Healthcare Purchase 1p Ordinary Securities
PRESS RELEASE published on 03/02/2026 at 15:14, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% interest in Just Group plc's 10p ordinary securities on 27 Feb 2026 Securities The Vanguard Group, Inc. Disclosure Interest Just Group Plc
PRESS RELEASE published on 03/02/2026 at 15:12, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.31% stake in LondonMetric Property plc as of 27 Feb 2026. Form 8.3 filed LondonMetric Property Plc Form 8.3 The Vanguard Group Financial Disclosure Stake Disclosure
PRESS RELEASE published on 03/02/2026 at 15:12, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses 1.13% ownership in International Personal Finance plc. Details of position disclosure under Rule 8.3 of the Takeover Code The Vanguard Group Rule 8.3 Takeover Code Ownership Disclosure International Personal Finance Plc
PRESS RELEASE published on 03/02/2026 at 15:11, 6 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.87% ownership in NCC Group plc shares as of 27 February 2026 The Vanguard Group Ownership Disclosure Stock Market Financial Holdings NCC Group Plc
Published on 09/11/2026 at 04:00, 5 hours 34 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 9 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 14 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 34 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 14 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 29 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 34 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 4 minutes ago Availability of the 2026 Interim Financial Report
